2017 ACC/AAP/AHA Health Policy Statement on Opportunities and Challenges in Pediatric Drug Development: Learning From Sildenafil-Reference-Cited by-同舟云学术

2017 ACC/AAP/AHA Health Policy Statement on Opportunities and Challenges in Pediatric Drug Development: Learning From Sildenafil

Published:2017-07 Issue:4 Volume:70 Page:495-503
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Sable Craig A.,Ivy D. Dunbar,Beekman Robert H.,Clayton-Jeter Helene D.,Jenkins Kathy J.,Mahle William T.,Morrow William R.,Murphy Mary Dianne,Nelson Robert M.,Rosenthal Geoffrey L.,Stockbridge Norman,Wessel David L.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference31 articles.

1. Pediatric cardiovascular drug trials, lessons learned;Li;J Cardiovasc Pharmacol,2011

2. Pediatric information in drug product labeling;Sachs;JAMA,2012

3. Evidence-based guidelines for pediatric clinical trials: focus on StaR Child Health;Sampson;Expert Rev Clin Pharmacol,2012

4. Off-label and unlicensed drug prescribing in three paediatric wards in Finland and review of the international literature;Lindell-Osuagwu;J Clin Pharm Ther,2009

5. Off-label and unlicensed prescribing for newborns and children in different settings: a review of the literature and a consideration about drug safety;Cuzzolin;Expert Opin Drug Saf,2006

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bioethics for Neonatal Cardiac Care;Pediatrics;2022-11-01

2. Mandatory requirements for pediatric drug development in the EU and the US for novel drugs—A comparative study;Frontiers in Medicine;2022-10-31

3. Treatment of pediatric pulmonary arterial hypertension: A focus on the NO‐sGC‐cGMP pathway;Pediatric Pulmonology;2019-07-16

4. Correction;Journal of the American College of Cardiology;2017-09